PMCB vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

PMCB

38.5
AI Score
VS
CLYM Wins

CLYM

41.4
AI Score

Investment Advisor Scores

PMCB

39score
Recommendation
SELL

CLYM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PMCB CLYM Winner
Net Income -19.42M -27.22M PMCB
Operating Income -6.85M -30.57M PMCB
ROE -58.3% -11.4% CLYM
ROA -41.5% -11.1% CLYM
Total Assets 46.75M 246.29M CLYM
Cash 18.60M 44.11M CLYM
Current Ratio 45.28 31.45 PMCB

Relative Price Performance (Last 90 Days)

PMCB 1M: -17.8% · 3M: -40.0% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

PMCB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.3%), weak momentum, RSI 27

RSI (14): 27.4 · Price: $0.45

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric PMCB CLYM
Market Cap
Forward P/E 7.0 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -2.77 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.